Investors

|

Portal
Order
Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

Innovation

Publications

Back

Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

– Caris Life Sciences

Poster

Background

A great need exists for new therapeutic approaches for patients with pancreatic cancer

Download Publication

Discover
More

  • Differential Impact of Tumor-Derived ESR1 Mutations on Elacestrant Benefit in Metastatic Breast Cancer

    – Caris Life Sciences

    Manuscript

    Abstract Purpose: ESR1 mutations are a well-established mechanism of endocrine therapy resistance in estrogen receptor (ER)–positive metastatic breast cancer and are a biomarker for treatment… […]

  • Toward Precision Extended Endocrine Therapy in Early HR+ Breast Cancer Multimodal AI for Risk and Benefit Stratification

    – Caris Life Sciences

    Poster

    Background […]
Learn More

Ready to Get Started on the Journey?